← FDA Drug Approvals (Drugs@FDA)
LABETALOL HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1999-09-30
Drug application
- FDA Application #
ANDA075242- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LABETALOL HYDROCHLORIDE
- Generic name
- Labetalol Hydrochloride
- Active ingredients
- LABETALOL HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- HOSPIRA
- First approval
- 1999-09-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown